NPS Pharmaceuticals (NPSP) Inactive 10-K2003 FY Annual report

Filed: 10 Feb 04, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: Addendum, anabolic, analyze, analyzed, analyzing, antiresorptive, Antitakeover, aspiration, asthma, Australia, backflow, baseline, Bio, bioequivalency, Biomedical, blockage, calcitonin, Carolina, Chapel, complimentary, composed, concurrent, condensed, consuming, contraindicated, conversion, cortical, Daniel, delucemine, difficulty, distraction, District, downtown, Drucker, easier, EITF, elderly, eleven, EMEA, encourage, encouraging, England, epithelium, ergonomically, esophageal, feedback, Film, foot, Fourteen, frequency, Galaxy, gastroesophageal, gathering, gender, GERD, GlaxoWellcome, ground, Harrison, heartburn, Hill, Houston, hundred, hypercalcemia, Hyphen, IIa, inclusive, indenture, inhibitor, insolvency, instance, internationally, isovaleramide, issuable, JCEM, land, linked, Lung, mandatorily, markedly, Medicab, Miravant, moderate, nausea, Nonemployee, noteholder, notification, obstruction, Open, Osteosarcoma, overhead, owed, peritoneal, presence, processed, proportionately, province, Qualitative, Quantitative, Quebec, race, rank, rat, Rauch, recur, redemption, reflux, refundable, regime, relaxation, relevant, relief, remission, remuneration, renowned, rent, repurchasing, reputation, resale, satisfactory, semiannually, sensitivity, serotonin, settlement, seventeen, situated, sphincter, spread, Star, step, stomach, stricture, Supplementary, symposium, SynCo, synergy, synthesize, teduglutide, teriparatide, thirteen, throat, trabecular, transient, Trustee, turnover, ulcer, Union, unpaid, unsecured, upfront, Vetter, vocal, volume, volumetric, vomiting, YESx, Zealand

Removed: absorptive, accomplish, aimed, altered, AMG, arose, bid, Boston, characterization, CIBC, closed, collaborating, combined, conference, confirming, determinable, Education, emerged, energy, Finally, framework, Freston, Fuel, Graduate, Hectoral, hereof, increasing, Index, Industrial, ineffective, integrated, invoiced, lawful, lawfully, measurement, Mountain, noncash, notwithstanding, NX, obligated, original, Patricia, predicted, principle, Programming, prove, Psychology, Questar, ratifying, reacquire, recognizing, reflect, relieve, RenaGel, resolution, resubstitution, returned, signature, stead, substitute, substitution, tangible, therewith, thing, traded, true, unsafe, virtue, waiver

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

NPSP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 23.1

Consent of Independent Auditors

The Board of Directors and Stockholders

NPS Pharmaceuticals, Inc.

We consent to incorporation by reference in the registration statements (Nos. 33-79622, 333-17521, and 333-94269) on Forms S-8 and (Nos. 333-41758, 333-106770 and 333-108612) on Forms S-3 of NPS Pharmaceuticals, Inc. of our report dated February 9, 2004, relating to the consolidated balance sheets of NPS Pharmaceuticals, Inc. and subsidiaries (a development stage enterprise) as of December 31, 2003 and 2002, and the related consolidated statements of operations, stockholders’ equity and comprehensive income (loss), and cash flows for each of the years in the three-year period ended December 31, 2003, and for the period from October 22, 1986 (inception) to December 31, 2003, which report appears in the December 31, 2003 annual report on Form 10-K of NPS Pharmaceuticals, Inc.

Our report refers to a change in the method of amortizing goodwill and intangible assets in 2002.

/s/ KPMG LLP

Salt Lake City, Utah

February 9, 2004